IPCURE is a French biotech pioneering 1st-in-class, highly selective Caspase-2 inhibitors to preserve memory in dementias. Our flagship candidate targets Frontotemporal Dementia with a clear line of sight to Alzheimer’s disease. Backed by strong IP we are advancing toward IND-enabling studies and early clinical proof-of-concept.